Legal Opinion

Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals, LLC

District Court, D. Delaware

Decided October 7, 2016No. Civil Action No. 14-1382-RGA, Civil Action No. 14-1389-RGAPublished

1Opinion of the Court

TRIAL OPINION

ANDREWS, UNITED STATES DISTRICT JUDGE:

Plaintiffs brought these patent infringement actions against Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals of New York, LLC (collectively, “Amneal”), Teva Pharmaceuticals USA, Inc., and Barr Laboratories, Inc. (collectively, “Teva”) in 2014. (D.I. 1).1 On April 3, 2012, Amneal filed an Abbreviated New Drug Application (“ANDA”), seeking to engage in the commercial manufacture, use, and sale of generic versions of Endo’s Opana ER CRF product.2 (D.I. 130, Ex. ¶ 14). Teva filed an ANDA on April 17, 2012, with amendments on May 4, 2012 and…

2Cases cited30 opinions

Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
Amgen Inc., Plaintiff-Cross v. Hoechst Marion Roussel, Inc. (Now Known as Aventis Pharmaceuticals, Inc.) and Transkaryotic Therapies, Inc.Court of Appeals for the Federal Circuit · 2003
Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
Bayer Ag and Bayer Corporation v. Elan Pharmaceutical Research Corporation and Elan Corporation, PlcCourt of Appeals for the Federal Circuit · 2000

25 more not listed; retrieve them via the Exa API.